US open futures mixed as yields fall Powell and Yellen in focus
Treasury yields ease after soothing words from Fed Powell over the weekend. Tech stocks rise, cyclicals are out of favour.
Share this:
US futures
Dow futures -0.03% at 32599
S&P futures +0.2% at 3917
Nasdaq futures +0.74% at 12950
In Europe
FTSE -0.03% at 6715
Dax +0.06% at 14650
Euro Stoxx -0.01% at 3836
Learn more about trading indices
Stocks set for higher start as yields ease
Tech stocks are set to outperform thanks to a fall in US bond yields, as investors buy back into growth stocks. The tech heavy Nasdaq futures are pushing ahead at the expense of the Dow and a rotation out of cyclicals.
Yields on the bench mark 10 year treasury fell -3.3% to 1.67%, well down from last week’s 14 month high of 1.75% after Fed policy makers calmed the bond market bears over the weekend. Fed Chair Powell wrote in the Wall Street journal that the recovery in the US economy is far from complete and that the Fed will continue to provide the support needed. Richmond Fed President Thomas Barkin also said in an interview that there were no signs of undesirable inflation.
The US Dollar gave up safe haven gains in early trade and how moves lower on the yield trade.
Stocks in focus
GameStop – trades -0.6% pre-market but could see some volatility ahead of earnings later. There are questions over how much fundamentals really matter for this stocks which has been central to the populist short squeeze movement of day traders versus hedge funds.
Tesla -trades +3% pre-market after Cathie Wood’s Ark Investment said that the share price could reach $3000 by 2025. Cathie wood’s view carry weight on Wall Street.
Where next for Tesla share price?
After rallying to an all time high at the start of the year, Tesla has been trending lower. The share price found a floor at 540.00 rebounding slightly. The share price has traded range bound capped on the lower band by 615.00 and the upper band at 720.00.
Today’s jump high has pushed the share price back over the 20 sma on the daily chart. However it remains below the 50 sma and the RSI is also relatively neutral. It could be prudent to wait for a break out of the said levels before placing any aggressive buy or sell trades.
US trials boost AstraZeneca, EU vaccine crisis deepens
AstraZeneca ADRs – trades +2% pre-market after the US trial revealed that its covid vaccine was 79% effective, 100% effective in preventing hospitalization, was as effective for over 65s and didn’t increase the risk of blood clotting. This some well needed good news for the jab after European governments raised doubts over its safety.
The results come as Germany is set to join France in extending lockdown restrictions through until the middle of April amid a surge in new cases.
India has also reported its highest daily infection rate for 4 months whilst numbers in Brazil and Chile hit new records.
FX – Turkish Lira collapses
The US Dollar gave up safe haven gains in early trade and how moves lower on the yield trade.
The Turkish Lira plunged to its weakest level versus the USD on the open, tanking some 14% to 8.4836 after President Erdogan unexpectedly sacked the central bank governor Naco Agbal. The move sparked fears that Turkey could see interest rates fall again, creating further inflationary pressure.
USD/TRY has since eased back off all time highs and trades +9.7% at 7.9206.
Elsewhere the FX markets have remained relatively muted, with little in the way of fresh catalysts to direct trading.
Investors await Fed Chair Powell’s testimony before congress together with US treasury secretary Janet Yellen.
GBP/USD 0% at 1.3865
EUR/USD trades +0.2% at 1.1927
Oil turns after weaker start
US crude oil is attempting to push higher after steep losses across the previous week. Oil shed over 6%last week and opened today’s session lower amid rising concerns over a third wave of covid in Europe and tighter lockdown restrictions.
US crude trades -.1% at $61.37
Brent trades -0.3% at $64.23
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
13:00 Fed Powell speech
14:00 Existing home sales
US futures
Dow futures -0.03% at 32599
S&P futures +0.2% at 3917
Nasdaq futures +0.74% at 12950
In Europe
FTSE -0.03% at 6715
Dax +0.06% at 14650
Euro Stoxx -0.01% at 3836
Learn more about trading indices
Stocks set for higher start as yields ease
Tech stocks are set to outperform thanks to a fall in US bond yields, as investors buy back into growth stocks. The tech heavy Nasdaq futures are pushing ahead at the expense of the Dow and a rotation out of cyclicals.
Yields on the bench mark 10 year treasury fell -3.3% to 1.67%, well down from last week’s 14 month high of 1.75% after Fed policy makers calmed the bond market bears over the weekend. Fed Chair Powell wrote in the Wall Street journal that the recovery in the US economy is far from complete and that the Fed will continue to provide the support needed. Richmond Fed President Thomas Barkin also said in an interview that there were no signs of undesirable inflation.
The US Dollar gave up safe haven gains in early trade and how moves lower on the yield trade.
Stocks in focus
GameStop – trades -0.6% pre-market but could see some volatility ahead of earnings tomorrow. There are questions over how much fundamentals really matter for this stocks which has been central to the populist short squeeze movement of day traders versus hedge funds.
Tesla -trades +3% pre-market after Cathie Wood’s Ark Investment said that the share price could reach $3000 by 2025. Cathie wood’s view carry weight on Wall Street.
Where next for Tesla share price?
After rallying to an all time high at the start of the year, Tesla has been trending lower. The share price found a floor at 540.00 rebounding slightly. The share price has traded range bound capped on the lower band by 615.00 and the upper band at 720.00.
Today’s jump high has pushed the share price back over the 20 sma on the daily chart. However it remains below the 50 sma and the RSI is also relatively neutral. It could be prudent to wait for a break out of the said levels before placing any aggressive buy or sell trades.
US trials boost AstraZeneca, EU vaccine crisis deepens
AstraZeneca ADRs – trades +2% pre-market after the US trial revealed that its covid vaccine was 79% effective, 100% effective in preventing hospitalization, was as effective for over 65s and didn’t increase the risk of blood clotting. This some well needed good news for the jab after European governments raised doubts over its safety.
The results come as Germany is set to join France in extending lockdown restrictions through until the middle of April amid a surge in new cases.
India has also reported its highest daily infection rate for 4 months whilst numbers in Brazil and Chile hit new records.
FX – Turkish Lira hits all time low
The US Dollar gave up safe haven gains in early trade and how moves lower on the yield trade.
The Turkish Lira plunged to its weakest level versus the USD on the open, tanking some 14% to 8.4836 after President Erdogan unexpectedly sacked the central bank governor Naco Agbal. The move sparked fears that Turkey could see interest rates fall again, creating further inflationary pressure.
USD/TRY has since eased back off all time highs and trades +9.7% at 7.9206.
Elsewhere the FX markets have remained relatively muted, with little in the way of fresh catalysts to direct trading.
Investors await Fed Chair Powell’s testimony before congress together with US treasury secretary Janet Yellen.
GBP/USD 0% at 1.3865
EUR/USD trades +0.2% at 1.1927
Oil turns after weaker start
US crude oil is attempting to push higher after steep losses across the previous week. Oil shed over 6%last week and opened today’s session lower amid rising concerns over a third wave of covid in Europe and tighter lockdown restrictions.
US crude trades -.1% at $61.37
Brent trades -0.3% at $64.23
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
13:00 Fed Powell speech
14:00 Existing home sales
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
S&P 500, Nasdaq, Dow Forecast: Wall Street Split Widens Into Month-End 9 26 2026
Nasdaq strength contrasts with mounting Dow pressure as rising Treasury yields raise the stakes for stocks heading into the monthly close.
EUR/USD weekly outlook: Oil, inflation and NFP in focus
After coming under significant pressure in recent weeks, the EUR/USD came off its lows to finish the week on a positive note on Friday, albeit with only a mild rebound. That was not enough to prevent the exchange rate falling for the third consecutive week, as the US dollar and bond yields rallied across the board.
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.